Blog

63 Articles

microscope on a blue background
Research
December 29, 2021 • 8 Min

Pancreatic Cancer Science—2021 in Review

As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.

Gastroenterologist Dr. Venkata Akshintala
Symptoms
September 20, 2021 • 4 Min

Precursors to Pancreatic Cancer: Are There Any Signs to Watch Out For?

Dr. Venkata Akshintala outlines some of the precursors to pancreatic cancer that people should look out for.

orange and blue kaleidoscopic pattern
Research
August 11, 2021 • 2 Min

Testing a PARP Inhibitor for Metastatic Pancreatic Cancer Patients with DNA Repair Mutations

Researchers are testing a PARP inhibitor that is effective for cancers in pancreatic cancer patients with DNA repair mutations.

Gehan Botrus
Research
July 26, 2021 • 5 Min

Finding More Clues about Circulating Tumor DNA

Researcher Dr. Gehan Botrus looks at circulating tumor DNA for genetic information on a patient’s pancreatic cancer to personalize treatment.

Lab worker holding pipette
Research
July 16, 2021 • 2 Min

Identifying Biomarkers for Early Detection of Pancreatic Cancer

A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.

abstract DNA image in bright greens and reds
Research
May 25, 2021 • 2 Min

PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations

A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.

multicolored abstract DNA against a black background
Research
April 29, 2021 • 3 Min

Chemotherapy Plus Stem Cell Infusion and Vitamins for BRCA Mutated Pancreatic Cancer

A clinical trial for pancreatic cancer patients with a BRCA mutation uses a combination of chemotherapy, vitamins, and stem cells.

Learn the Risk Factors webinar announcement
Webinars
February 26, 2021 • 1 Min

Learn the Risk Factors

In the first Let’s Learn webinar, Learn the Risk Factors, experts explain how diabetes, genetic mutations, and pancreatitis impact pancreatic cancer.

Green and red microscope
Research
December 30, 2020 • 6 Min

A Year in Review: 2020

In March 2020, life as we knew it changed. The way we work, the way we gather, the way we each live our daily lives all felt upended, seemingly overnight. The global pandemic of COVID-19 affected everything, including cancer care and research. COVID-19 brought new risks to cancer patients, whose immune systems are compromised from […]

colored lights in 1/4 of a circle
Research
November 6, 2020 • 2 Min

An Expanded Access Trial for Cancer Patients with Specific Mutations

An investigational drug is being used in an expanded access trial for advanced pancreatic and other cancer patients with specific genetic changes.

Let's Win, Lustgarten Foundation, and AACR logos
Research
October 1, 2020 • 8 Min

AACR Virtual Special Conference on Pancreatic Cancer: Day Two Highlights

Let’s Win and the Lustgarten Foundation present highlights of Day Two of the AACR Virtual Special Conference on Pancreatic Cancer.

Let's Win, Lustgarten Foundation, and AACR logos
Research
September 30, 2020 • 7 Min

AACR Virtual Special Conference on Pancreatic Cancer: Day One Highlights

Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.

Dr. Sapna Syngal
Research
July 2, 2020 • 4 Min

GENERATE Trial Expands Eligibility

Dr. Sapna Syngal explains the expanded eligibility standards for the GENERATE Study for genetic testing of pancreatic cancer patients and relatives.

DNA aqua pipette
Research
February 26, 2020 • 6 Min

Exploiting DNA Mutations For Pancreatic Cancer Treatment

Dr. James Cleary explains how the researchers at Dana-Farber are looking to make PARP inhibitors even more effective for pancreatic cancer patients.

PARP inibitor olaparib
Research
December 23, 2019 • 5 Min

Looking Back at the Year in Research: 2019

Research highlights of 2019 include: approval of a PARP inhibitor, artificial intelligence to diagnose pancreatic cysts, and updated radiation guidelines.